One-year observation of inflammatory markers in patients with aortic valve stenosis

Journal of Heart Valve Disease

Volumn 20, Issue 6, 2011, Pages 639-649

  Swierszcz, Jolanta ^a   Dubiel, Jacek S ^a   Krzysiek, Jozef ^a   Sztefko, Krystyna ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b University Children Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; C REACTIVE PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; IL6 PROTEIN, HUMAN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; AORTA VALVE STENOSIS; ARTICLE; BODY MASS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; BLOOD; ECHOGRAPHY; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

AGED; ANTIBODIES, BACTERIAL; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHLAMYDOPHILA PNEUMONIAE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862982817     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sanchez PL, Mazzone AM. C-reactive protein in aortic valve disease. Cardiovasc Ultrasound 2006;4,37:1-4
2. Mautner GC, Mautner SL, Cannon RO, Hunsberger SA, Roberts WC. Clinical factors useful in predicting aortic valve structure in patients >40 years of age with isolated valvular aortic stenosis. Am J Cardiol 1993;72:194-198
3. Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkila J, Tilvis R. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994;15:865-870
4. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997;29:630-634
5. Kaden JJ, Haghi D, Vocke DC, Brueckmann M, Suselbeck T, Borggrefe M. Chlamydia pneumonia - a new risk factor for calcific aortic stenosis? Med Klin (Munich) 2005;15:334-339
6. Juvonen J, Laurila A, Juvonen T, et al. Detection of Chlamydia pneumoniae in human non rheumatic stenotic aortic valves. J Am Coll Cardiol 1997;29:1054-1059
7. Galante A, Pietroiusti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078-1082
8. Kapadia SR, Yakoob K, Nader S, Thomas JD, Mann DL, Griffin BP. Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol 2000;36:208-212
9. Gunduz H, Akdemir R, Binak E, Tamer A, Keser N, Uyan C. Can serum lipid and CRP levels predict the 'severity' of aortic valve stenosis ? Acta Cardiol 2003;58:321-326
10. Skowasch D, Schrempf S, Preusse CJ, et al. Tissue resident C reactive protein in degenerative aortic valves: Correlation with serum C reactive protein concentrations and modification by statins. Heart 2006;92:495-498
11. Rajamannan NM, Subramanian M, Springett M, et al. Atorvastatin inhibits hypercholesterolemiainduced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002;105:2660-2069
12. Agmon Y, Khandheria BK, Jamil Tajik A, et al. Inflammation, infection, and aortic valve sclerosis: Insights from the Olmsted County (Minnesota) population. Atherosclerosis 2004;174:337-342
13. .Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268
14. Swierszcz J, Dubiel JS, Milewicz T, Sztefko K, Krzysiek J. Smoking, increase in plasma lipoprotein(a) and triglycerides, as well as decrease in plasma HDL-cholesterol concentrations seem to be linked with aortic valve stenosis and its progression. Przegl Lek 2009;66:159-165
15. Jeevanantham V, Singh N, Izuora K, D'Souza JP, His DH. Correlation of high sensitivity C-reactive protein and calcific aortic valve disease. Mayo Clin Proc 2007;82:171-174
16. Sanchez PL, Santos JL, Kaski JC, et al. Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 2006;97:90-93
17. Imai K, Okura H, Kume T, et al. C-Reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis. Am Heart J 2008;156:713-718
18. Andropova OV, Polubentseva EI. Aortic valve stenosis: Persistence of infective agents or noninfective inflammatory process? Antibiot Khimioter 2004;49:28-30
19. Hsu SY, Hung KC, Chang SH, Wen MS, Hsieh IC. C-reactive protein in predicting coronary artery disease in subjects with aortic valve sclerosis before diagnostic coronary angiography. Am J Med Sci 2006;331:264-269
20. Toli K, Paraskevas KI, Poulakou MV, et al. Association between plasma levels and immunolocalization of cytokines in heart valve lesions: A possible target for treatment? Expert Opin Ther Targets 2008;12:1209-1215
21. Yu Z, Seya K, Daitoku K, Motomura S, Fukuda I, Furukawa KI. TNF-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway. J Pharmacol Exp Ther 2011;337:16-23
22. Turgeman Y, Levahar P, Lavi I, et al. Adult calcific aortic stenosis and Chlamydia pneumoniae: The role of Chlamydia infection in valvular calcification. Isr Med Assoc J 2006;8:464-468
23. Butchart EG, Ionescu A, Payne N, Giddings J, Grunkemeier GL, Fraser AG. A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 2003;108(Suppl.1):68-74
24. Mohler ER, III, Wang H, Medenilla E, Scott C. Effect of statin treatment on aortic valve and coronary artery calcification. J Heart Valve Dis 2007;16:378-386
25. Kastellanos SS, Toumpoulis IK, Aggeli C, et al. The role of sex and biochemical markers of inflammation in left ventricular remodelling, before and after surgery, in elderly patients with aortic valve stenosis. Hellenic J Cardiol 2009;50:26-36